ST Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
ST is not a good buy right now. The short-term technical setup is weakening (negative and expanding MACD histogram, price below/near pivot with downside probabilities over the next week/month), and the most concerning signal is the sharp acceleration in insider selling. With no Intellectia buy signals today and limited near-term catalysts beyond a small dividend, the risk/reward is unfavorable for an impatient buyer looking for immediate upside.
Trend/Setup: Bearish-to-neutral. MACD histogram (-0.139) is below zero and negatively expanding, indicating downside momentum is building. RSI(6) ~43 is neutral but leaning weak (not oversold), so there isn’t a clear mean-reversion buy signal. Moving averages are converging, which often precedes a direction move; current momentum favors downside. Key levels: Pivot 34.877 is the near-term line in the sand. ST is slightly below/around this area post-market at 34.59, which is a mild bearish posture. Support levels sit at S1 33.93 then S2 33.345 (areas where buyers may appear). Resistance levels are R1 35.825 then R2 36.41 (levels that must be reclaimed to flip the short-term trend bullish). Pattern-based odds: Similar-pattern analysis suggests modest downside bias (-1.34% next week, -3.26% next month), which aligns with the MACD deterioration.
on 2026-02-19 after hours could be a catalyst if results/guide surprise positively.
Insiders are selling, with selling amount reportedly up 7372.91% over the last month—this is a major negative sentiment/capital allocation signal.
Technical momentum is weakening (MACD below zero and worsening) with the stock sitting below/near the pivot and downside-biased short-term pattern probabilities.
Latest quarter showed revenue down -5.17% YoY, indicating top-line pressure.
No hedge fund accumulation signal (neutral) and no Intellectia proprietary buy signals today to override the cautious setup.
Latest reported quarter: 2025/Q3. Revenue declined to 931,978,000 (-5.17% YoY), indicating contraction on the top line. Profitability improved materially YoY (net income and EPS increased YoY), and gross margin rose to 25.73 (+6.85% YoY), but net income and EPS remain negative in this snapshot (still loss-making). Overall: improving margins/loss trend, but weakening demand/revenue is a headwind.
No analyst rating or price target change data was provided, so a verified trend in upgrades/downgrades cannot be summarized. Based on the data at hand, the most credible ‘pros vs cons’ view would be: Pros—margin improvement and a maintained dividend; Cons—revenue decline, deteriorating short-term technicals, and heavy insider selling (the strongest negative signal in this dataset).
